Broadcom said to offer remedies to EU over antitrust issues on VMware deal
Justin Sullivan/Getty Images News
Broadcom (NASDAQ:AVGO) has reportedly offered some remedies to regulators in the European Union in an attempt to assuage antitrust concerns over its pending $61B deal for VMware (NYSE:VMW).
Filings made by the European Commission on Wednesday showed that Broadcom (AVGO) had previously submitted its proposal, though the filing did not provide details. 
In addition, the EU extended its deadline for a decision to July 17, Reuters reported.
Broadcom (AVGO) shares were fractionally higher in pre-market trading on Wednesday, while VMware was little changed.
Last week, it was reported that Broadcom (AVGO) was expected to offer a behavioral remedy to the European Commission to try to alleviate the regulators' concerns about interoperability.
In April, the EC sent Broadcom (AVGO) a "statement of objections" over its proposed deal to buy VMware (VMW). It said it was concerned Broadcom (AVGO) may "restrict competition in the global markets for the supply of FC HBAs and storage adapters by foreclosing competitors' hardware by delaying or degrading their access to VMware's server virtualization software."
More on Broadcom, VMware deal

An Updated View On Broadcom
What Is VMware Worth If The Broadcom Deal Fails?
VMware potential deal price break raised to $115 from $100 at UBS